FDA Warns of False Positives for Zika Test

Dec 23, 2016

NEW YORK (360Dx) – The US Food and Drug Administration said today that Laboratory Corporation of America reported false-positive results using the first commercially available Zika serological IgM test, which is manufactured by InBios International.

As a result, the FDA issued recommendations to physicians using the test not to depend solely on it to diagnose patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Breaking News

Featured White Papers

Molecular Tests Provide a Better Alternative to Stool Culture for GI Cases

Jan

30

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb

26

Featured Webinar

A Cellular and Molecular Phenotyping Pipeline for Target Characterization in FFPE Biobank Samples

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.

Main menu